
    
      The trial is a multicenter, randomized, controlled trial in renal transplant subjects aged 18
      to 60 years who are non-responders to vaccination with the reference vaccine. Subjects will
      be randomized to receive either the 2007-2008 15 Âµg investigational vaccine or the 2007-2008
      IM reference vaccine.
    
  